Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00476
|
|||||
Drug Name |
Clomipramine
|
|||||
Synonyms |
10,11-dihydro-3-chloro-5-(3-(dimethylamino)propyl)-5H-dibenz(b,f)azepine; 3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine; 3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine; 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine; 3-Chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine; 3-Chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine; 3-Chloroimipramine; 3-chloro-10,11-dihydro-N,N-dimethyl-5H-Dibenz(b,f)azepine-5-propanamine; 5H-Dibenz(b,f)azepine, 3-chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-(8CI); Anafranil (TN); Anafranil (free base); Anafranil base; Chlomipramine; Chlorimipramine; Clomicalm; Clomipramina; Clomipramina [INN-Spanish]; Clomipramine (INN); Clomipramine [INN:BAN]; Clomipraminum; Clomipraminum [INN-Latin]; G 34586; Hydiphen; Monochlorimipramine
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Depression [ICD11: 6A8Z] | Approved | [1] | |||
Therapeutic Class |
Antidepressants
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C19H23ClN2
|
|||||
Canonical SMILES |
CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
|
|||||
InChI |
InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3
|
|||||
InChIKey |
GDLIGKIOYRNHDA-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 303-49-1
|
|||||
Pharmaceutical Properties | Molecular Weight | 314.9 | Topological Polar Surface Area | 6.5 | ||
Heavy Atom Count | 22 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
XLogP |
5.2
|
|||||
PubChem CID | ||||||
PubChem SID |
10517818
, 11110978
, 11110979
, 11113368
, 11335972
, 11361211
, 11363338
, 11365900
, 11368462
, 11372613
, 11373898
, 11376624
, 11462183
, 11466297
, 11467417
, 11485514
, 11486073
, 11489545
, 11491522
, 11492165
, 11494258
, 15322462
, 26751616
, 29214813
, 29221956
, 3249337
, 3288049
, 442468
, 46505157
, 47216808
, 47291176
, 47440300
, 47440301
, 47515346
, 47810787
, 47959785
, 48035161
, 48035162
, 4806772
, 48110484
, 48110485
, 48110486
, 48334532
, 48415804
, 49698951
, 49961439
, 623914
, 7978972
, 8151810
, 9135
|
|||||
ChEBI ID |
ChEBI:47780
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Clomipramine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Improving the prediction of the brain disposition for orally administered drugs using BDDCS. Adv Drug Deliv Rev. 2012 Jan;64(1):95-109. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.